Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

In utero hematopoietic stem cell therapy

Hayashi S, Flake AW

In utero hematopoietic stem cell transplantation (IUHSCTx) is a promising approach for the treatment of a potentially large number of fetuses affected by congenital hematologic disorders. With technical advances in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical applications of mesenchymal stem cells

Kim N, Cho SG

Mesenchymal stem cells (MSCs) are self-renewing, multipotent progenitor cells with multilineage potential to differentiate into cell types of mesodermal origin, such as adipocytes, osteocytes, and chondrocytes. In addition, MSCs can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retrospective Analysis of Peripheral Blood Stem Cell Transplantation for the Treatment of High-Risk Neuroblastoma

Kim EK, Kang HJ, Park JA, Choi HS, Shin HY, Ahn HS

Disease relapse after autologous peripheral blood stem cell transplantation (APBSCT) is the main cause of treatment failure in high-risk neuroblastoma (NBL). To reduce relapse, various efforts have been made such...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hematopoietic Stem Cell Transplantation in Children with Leukemia: A Single Institution Experience with Respect to Donors

Baek HJ, Kook H, Han DK, Hwang TJ

Aim of this study was to compare the outcomes of transplantation by donor source and to help select the best alternative donor in children with leukemia. Donor sources included matched...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in treatment of aplastic anemia

Shin SH, Lee SE, Lee JW

Recent advances in the treatment of aplastic anemia (AA) made most of patients to expect to achieve a long-term survival. Allogeneic stem cell transplantation (SCT) from HLA-matched sibling donor (MSD-SCT)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis

Kim G, Eom YW, Baik SK, Shin Y, Lim YL, Kim MY, Kwon SO, Chang SJ

Based on their ability to differentiate into multiple cell types including hepatocytes, the transplantation of mesenchymal stem cells (MSCs) has been suggested as an effective therapy for chronic liver diseases....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mesenchymal stem cell therapy for liver fibrosis

Eom YW, Shim KY, Baik SK

Currently, the most effective treatment for end-stage liver fibrosis is liver transplantation; however, transplantation is limited by a shortage of donor organs, surgical complications, immunological rejection, and high medical costs....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation

Kim HJ, Chung IJ, Lee JJ, Seo JS, Park MR, Choi KS, Kook H, Hwang TJ

  • KMID: 759052
  • Korean J Intern Med.
  • 1998 Feb;13(1):60-63.
To overcome poor graft function after allogeneic bone marrow transplantation (BMT), the use of peripheral blood stem cells (PBSC) instead of bone marrow is gaining more popularity because of its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Membranous Nephropathy after Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: A Case Report

Kim KW, Yoon CH, Kay CS, Kim HJ, Suh KS, Kim SY, Park SY

Nephrotic syndrome has been described as one of the clinical forms of chronic graft-versus-host disease (cGVHD), but a limited number of cases have been described. We experienced a young female...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feasibility of Non-TBI Conditioning with Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation in Lymphoid Malignancy

Shin HC, Lee YJ, Moon JH, Lee SJ, Kang BW, Chae YS, Kim JG, Choi JY, Seo JW, Kim YK, Suh JS, Sohn SK

BACKGROUND/AIMS: This retrospective study evaluated the transplantation outcomes of patients with adult lymphoid malignancies who received chemotherapy-based conditioning with busulfan and fludarabine (BuFlu) and busulfan and cyclophosphamide (BuCy2). METHODS: Thirty-eight patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hemorrhagic Cystitis Following Allogeneic Hematopoietic Cell Transplantation

Lee GW, Lee JH, Choi SJ, Kim S, Seol M, Kim WK, Lee JS, Lee KH

We conducted a retrospective study to investigate the incidence, risk factors, and clinical features of hemorrhagic cystitis (HC) following allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients who developed HC after...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients

Park H, Rho EY, In JW, Kim I, Yoon SS, Park S, Shin S, Park KU, Song EY

BACKGROUND: The impact of HLA and KIR ligand mismatching on the outcome of hematopoietic stem cell transplantation (HSCT) remains unclear. Previous reports have identified considerable ethnic differences in the impact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Implications of the NIH Consensus Criteria in Children with Chronic Graft-versus-Host Disease

Lee JW, Lee DH, Jang PS, Yi MS, Chung NG, Cho B, Jeong DC, Kim HK

PURPOSE: In this study, we analyzed a cohort of children with chronic graft-versus-host disease (GvHD) according to the NIH consensus classification (NCC) in order to observe whether global assessment at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Related to Decreased Bone Mineral Density in Childhood Cancer Survivors

Choi YJ, Park SY, Cho WK, Lee JW, Cho KS, Park SH, Hahn SH, Jung MH, Chung NG, Cho B, Suh BK, Kim HK

The risk of osteoporosis or osteopenia is known to increase after childhood cancer treatment. The purpose of this study was to evaluate patterns of bone mineral density (BMD) and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea

Hong KW, Choi SM, Lee DG, Cho SY, Lee HJ, Choi JK, Kim SH, Park SH, Choi JH, Yoo JH, Lee JW

PURPOSE: To describe the incidence, clinical courses, and risk factors for mortality of lower respiratory tract diseases (LRDs) caused by common respiratory viruses (CRVs) in stem cell transplantation (SCT) recipients. MATERIALS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr